¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"skin test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • test object
    ½ÃÇè´ë»ó, Ç¥½Ä¹°
  • parametric test
    ÁöÇ¥°ËÁ¤
  • passive mobility test
    ¼º´ë°¡µ¿°Ë»ç
  • pastpointing test
    Áö½Ã°Ë»ç
  • patch test
    ºÎÂøÆ÷°Ë»ç, øÆ÷°Ë»ç
  • paternity test
    Ä£ÀÚ°¨Á¤
  • pendular rotation test
    ÈçµéÀÌȸÀü°Ë»ç
  • penile tumescence test
    À½°æÆØÃ¢°Ë»ç
  • percent reactive antibody test
    ¹éºÐÀ²¹ÝÀÀÇ×ü°Ë»ç
  • percutaneous test
    °æÇǰ˻ç
  • performance test
    ¼öÇà°Ë»ç
  • pilot test
    ¿¹ºñ°Ë»ç
  • positioning nystagmus test
    À§Ä¡´«¶³¸²°Ë»ç, µÎÀ§º¯È¯¾ÈÁø°Ë»ç
  • postcoital test
    ¼º±³Èİ˻ç
  • potency test
    È¿´É°Ë»ç, ¿ª°¡½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • guaiac test
    °úÀ̾׽ÃÇè
  • gutta diaphot test
    öÁ¶¹ý(ôËðÎÛö) Ç÷¾×ÀÇ .
  • haemolytic plaque test
    ¿ëÇ÷ÇöóÅ©½ÃÇè.
  • hanging drop test
    ÇöÀû½ÃÇè(¡­ãËúÐ).
  • hardness test
    °æµµ½ÃÇè(ÌãöôãËúÐ).
  • harmonic acceleration test
    Á¶È­(¼º) °¡¼Ó°Ë»ç
  • head tilt test
    ¸Ó¸®±â¿ïÀÓ°Ë»ç, µÎÀ§°æ»ç°Ë»ç
  • hearing test
    û·Â°Ë»ç
  • hearing test, objective
    °´°üÀû û·Â°Ë»ç, Ÿ°¢Àû û·Â°Ë
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • hearing test, speech
    ¾îÀ½Ã»·Â°Ë»ç
  • heat and acetic acid test
    °¡¿Â¾Æ¼¼Æ®»ê½ÃÇè (¹ý)(ʥ计­ß«ãËúÐÛö).
  • heat instability test
    ¿­ ºÒ¾ÈÁ¤¼º ½ÃÇè<°Ë»ç>
  • heat stability test
    ¿­¾ÈÁ¤¼º°Ë»ç
  • heat test
    ¿­½ÃÇè(ËçËàÌ´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • bulbocavernous evoked-response test
    ±¸Çظéü À¯¹ß¹ÝÀÀ°Ë»ç
  • bulbocavernous reflex latency test
    ±¸Çظéü ¹Ý»ç½Ã°£ ÃøÁ¤°Ë»ç
  • calcium infusion test
    Ä®½· ºÎÇϰ˻ç
  • caloric test
    ¿Âµµ¾ÈÁø°Ë»ç
  • caloric test
    ¿­·®°Ë»ç(¡­ËþÞÛ), ³Ã¿Â °Ë»ç
  • capillary fragility test
    ¸ð¼¼(Ç÷)°üÃë¾à¼º ½ÃÇè.
  • carbohydrate fermentation test
    ź¼öÈ­¹° ¹ßÈ¿½ÃÇè
  • carbohydrate tolerance test
    ź¼öÈ­¹°ºÎÇϽÃÇè.
  • carbohydrate utilization test
    ź¼öÈ­¹° ÀÌ¿ë½ÃÇè
  • carbon clearance test
    ź¼ÒÁ¦°Å½ÃÇè.
  • carbon clearance test
    ź¼ÒÁ¦°Å´É½ÃÇè
  • carbon monoxide hemoglobin test
    ÀÓº´ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó½ÃÇè.
  • casein digestion test
    Ä«¼¼ÀÎ ºÐÇØ°Ë»ç
  • catalase test
    īŻ¶óÁ¦ °Ë»ç
  • catalase test
    īŻ·¹À̽º½ÃÇè(¡­ãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
SPF skin protection factor; specific-pathogen free; spectrophotofluorometer; S-phase fraction; split pro...
SPL skin potential level; sound pressure level; splanchnic; spontaneous lesion; staphylococcal phage lys...
SPP plural of species; Sexuality Preference Profile; skin perfusion pressure; suprapubic prostatectomy
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
FOBT Faecal occult blood test
FTND Fagerstrom Test for Nicotine Dependence
FUT Fibrinogen Uptake Test
FAT Fluorescent Antibody Test
FTA-ABS Fluorescent Treponema Antibody-Absorption test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • furfurol test
    Ǫ¸£Çª·Ñ ½ÃÇè
  • Haagensen test
    Çϰռ¾ ½ÃÇè
    ÇǰËÀÚ¸¦ ¾ÕÀ¸·Î ±ÁÈ÷°Ô ÇÏ¿© ÈäºÎÀÇ À±°ûÀ» °üÂûÇÏ´Â °ÍÀ¸·Î À¯¹æÀÇ ¾Ç¼º º¯È­¸¦ °üÂûÇÏ´Â ½ÇÇè.
  • Hamel's test
    ÇÏ¸á ½ÃÇè
    ±ÓºÒ¿¡¼­ õÀÚ·Î ¼Ò·®ÀÇ Ç÷¾×À» »Ì¾Æ¼­ 2-3½Ã°£ ¹æÄ¡ÇÒ ¶§ Ȳ´ÞÀÌ Á¸ÀçÇϸé Ç÷ûÀÌ È²»öÀ» ³ªÅ¸³½´Ù.
  • Hanger's test
    Çà°Å ½ÃÇè
    1. °£ ¼¼Æ÷ ÁúȯÀÌ ÀÖÀ¸¸é ¼¼ÆÈ¸° ÄÝ·¹½ºÅ×·Ñ À¯Å¹¾×¿¡ ¸é»ó ¹ÝÀÀÀÌ »ý±â´Â Çö»óÀ» ÀÌ¿ëÇÑ ½ÃÇè. 2. ÀÌ ÁúȯÀÇ Ç÷û¿¡ ÀÇÇØ¼­ ¼¼ÆÈ¸°-ÄÝ·¹½ºÅ×·Ñ
  • hapten inhibition test
    ÇÕÅÙ ÀúÇØ ½ÃÇè
    Ç×üÀÇ Ç׿ø Ư¼ö °áÇÕ ºÎÀ§¸¦ µ¤´Â ÇÕÅÙÀ» ÀÌ¿ëÇÏ¿© Ç׿ø °áÁ¤±âÀÇ Ç÷ûÇÐÀû Ư¼ºÀ» °Ë»çÇÏ´Â ½ÃÇè.
  • Harris and Ray test
    Ç츮½º-·¹ÀÌ ½ÃÇè
    ¿äÁßÀÇ ºñŸ¹Î C¿¡ ´ëÇÑ ¹Ì·® ÀûÁ¤¹ý.
  • heel to knee to shin test
    Á¾½½°æ ½ÃÇè
  • hemadsorption test
    Ç÷±¸ ÈíÂø ½ÃÇè
    Ç÷±¸ ÀÀÁý¼Ò Á¸Àç ½Ã¿¡ ÀûÇ÷±¸°¡ °¨¿°µÈ Á¶Á÷ÀÇ ¼¼Æ÷¿¡ À¯ÂøµÈ´Ù´Â »ç½ÇÀ» ±âÃÊ·Î ÇÏ¿© Ç÷±¸ ÀÀÁý¼º ¹ÙÀÌ·¯½º¸¦ °ËÃâÇÏ´Â »ýü¿Ü ½ÃÇè¹ýÀÌ´Ù.
  • hemagglutination inhibition test
    ÀûÇ÷±¸ ÀÀÁý ¾ïÁ¦ ½ÃÇè
  • hemaggutination test
    ÀûÇ÷±¸ ÀÀÁý ½ÃÇè
  • hematoporphyrin test
    Ç츶ÅäÆ÷¸£ÇǸ° ½ÃÇè
  • hemosiderin test
    Çì¸ð½Ãµ¥¸° Å×½ºÆ®, Ç÷ö¼Ò ½ÃÇè
  • Henry fructose test
    Ç °ú´ç °Ë»ç
  • Henshaw test
    Çî¼î¿ì ½ÃÇè
    ÁÖ¾îÁø Áúȯ¿¡ ´ëÇÑ Àû´çÇÑ È£¸Þ¿ÀÆÄƼ Ä¡·á ¾àÀÇ ¼±ÅÃÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â °Ë»ç¹ý .ÀÌ Áúȯ¿¡ ´ëÇÏ¿© È£¸Þ¿ÀÆÄƼÀûÀ¸·Î Áö½ÃµÈ °­È­ Ä¡·á¾à¿¡ ÇǰËÀÚÀÇ Ç÷ûÀ» Á¢Ã˽ÃÄ×À» ¶§ ´«¿¡ º¸ÀÌ´Â ¸é»ó ¹ÝÀÀ´ë°¡ ¹ßÇöµÇ¸é ¾çÈ£ÇÑ °ÍÀÌ´Ù.
  • Herzberg's test
    Ç츣Âê¹ö±× ½ÃÇè
    À§¾× Áß¿¡ À¯¸® ¿°»êÀÌ Á¸ÀçÇϸé Äá°í·¹µå ¿ë¾×ÀÌ Ã»»öÀ» ¶ì´Â ½ÃÇè.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
pentagastrin test An alternative to histamine for stimulation of acid secretion in gastric analysis.
(05 Mar 2000)
Gofman test A test for various serum lipoproteins that contain cholesterol, as an index of the tendency to the development of atheromatous lesions and arteriosclerosis; the test is based on the differential flotation of molecules of various sizes when the serum is treated in an ultracentrifuge.
(05 Mar 2000)
Meltzer-Lyon test A test used in diagnosis of gallbladder conditions: 25 ml of a 25% solution of magnesium sulfate are delivered into the region of the sphincter of Oddi through a duodenal tube, causing contraction of the gallbladder, relaxation of the sphincter, and the expulsion of bile from the common duct and gallbladder; bile from the common duct is relatively pale and is expelled first, that from the gallbladder follows; samples aspirated from the tube are examined for pus cells, pigment granules, epithelial cells, cholesterol, etc.
(05 Mar 2000)
Goldscheider's test Determination of the temperature sense by touching the skin with a sharp-pointed metallic rod, heated to varying degrees.
(05 Mar 2000)
gold sol test An obsolete, non-specific test for altered proteins in spinal fluid. As originally used by Lange in 1912, the test was thought to be specific for neurosyphilis; however, this proved to be incorrect. Dilutions of spinal fluid are made in saline and to these a colloidal gold solution is added; if altered proteins are present, there is a colour change or precipitate formed. at present, its chief use is to demonstrate cerebrospinal fluid protein abnormalities in multiple sclerosis.
Synonym: gold sol test, Zsigmondy's test.
(05 Mar 2000)
CF test <immunology> Binding of complement as a result of its interaction with immune complexes (the classical pathway) or particular surfaces (alternative pathway).
(18 Nov 1997)
Goodenough draw-alpha-man test A brief test for assessing an individual's level of intelligence based on how accurately drawn and how many elements are included when a child or adult is given a pencil and sheet of white paper and asked to draw a man, the best man he or she is able to draw. Also called the Goodenough draw-alpha-person test and, in its current form, the Goodenough-Harris drawing test.
(05 Mar 2000)
goodness of fit test A statistical test of the hypothesis that data have been randomly sampled or generated from a population that follows a particular theoretical distribution.
(05 Mar 2000)
Reuss' test A test for atropine; the addition of oxidizing agents and sulfuric acid to a liquid containing atropine produces an odour of orange-flowers and roses.
(05 Mar 2000)
performance test A test, such as five of the eleven Wechsler adult intelligence scale subtests, requiring little or no verbal instruction from the examiner and virtually no verbal response by the examinee.
(05 Mar 2000)
Gothlin's test <investigation> A capillary fragility test to determine the presence or absence of scurvy.
(05 Mar 2000)
Rh blocking test A test for nonagglutinating Rh antibodies: an Rh agglutination test is first carried out; if the test for Rh agglutinins is negative, then 1 drop of anti-Rho agglutinating serum of moderate titre is mixed with the patient's serum containing Rh-positive test cells; if after incubating for from 1 to 2 hr at 37°C no agglutination occurs, Rho-blocking antibodies are assumed to be present in the patient's serum.
(05 Mar 2000)
Graham-Cole test Radiography of the gallbladder after ingestion of a contrast medium.
(12 Dec 1998)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
Chick-Martin test A method of testing the in vitro efficiency of a bactericidal agent; a standard culture of Salmonella typhi which has been added to a fixed amount of sterilised faeces or yeast is tested for a fixed period (30 minutes), against various concentrations of phenol solution and various concentrations of the disinfectant; the result is expressed as a ratio: the phenol coefficient, which is the highest dilution of the disinfectant under test at which the bacteria are killed, divided by the highest dilution of phenol which sterilises the solution in the same length of time.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á